These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 33670902)

  • 1. Dysregulated CD38 Expression on Peripheral Blood Immune Cell Subsets in SLE.
    Burns M; Ostendorf L; Biesen R; Grützkau A; Hiepe F; Mei HE; Alexander T
    Int J Mol Sci; 2021 Feb; 22(5):. PubMed ID: 33670902
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Integrative analysis reveals CD38 as a therapeutic target for plasma cell-rich pre-disease and established rheumatoid arthritis and systemic lupus erythematosus.
    Cole S; Walsh A; Yin X; Wechalekar MD; Smith MD; Proudman SM; Veale DJ; Fearon U; Pitzalis C; Humby F; Bombardieri M; Axel A; Adams H; Chiu C; Sharp M; Alvarez J; Anderson I; Madakamutil L; Nagpal S; Guo Y
    Arthritis Res Ther; 2018 May; 20(1):85. PubMed ID: 29720240
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of BAFF, APRIL serum levels, BAFF-R, TACI and BCMA expression on peripheral B-cell subsets with clinical manifestations in systemic lupus erythematosus.
    Salazar-Camarena DC; Ortiz-Lazareno PC; Cruz A; Oregon-Romero E; Machado-Contreras JR; Muñoz-Valle JF; Orozco-López M; Marín-Rosales M; Palafox-Sánchez CA
    Lupus; 2016 May; 25(6):582-92. PubMed ID: 26424128
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased CD38 expression in T cells and circulating anti-CD38 IgG autoantibodies differentially correlate with distinct cytokine profiles and disease activity in systemic lupus erythematosus patients.
    Pavón EJ; Zumaquero E; Rosal-Vela A; Khoo KM; Cerezo-Wallis D; García-Rodríguez S; Carrascal M; Abian J; Graeff R; Callejas-Rubio JL; Ortego-Centeno N; Malavasi F; Zubiaur M; Sancho J
    Cytokine; 2013 May; 62(2):232-43. PubMed ID: 23538292
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PD-1+CXCR5-CD4+T cells are correlated with the severity of systemic lupus erythematosus.
    Lin J; Yu Y; Ma J; Ren C; Chen W
    Rheumatology (Oxford); 2019 Dec; 58(12):2188-2192. PubMed ID: 31180450
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of anti-interleukin-6 receptor blockade on circulating T and B cell subsets in patients with systemic lupus erythematosus.
    Shirota Y; Yarboro C; Fischer R; Pham TH; Lipsky P; Illei GG
    Ann Rheum Dis; 2013 Jan; 72(1):118-28. PubMed ID: 22858586
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification and characterisation of transient receptor potential melastatin 2 and CD38 channels on natural killer cells using the novel application of flow cytometry.
    Balinas C; Cabanas H; Staines D; Marshall-Gradisnik S
    BMC Immunol; 2019 May; 20(1):14. PubMed ID: 31077146
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-dsDNA production coincides with concurrent B and T cell activation during development of active disease in systemic lupus erythematosus (SLE).
    Spronk PE; Horst G; Van Der Gun BT; Limburg PC; Kallenberg CG
    Clin Exp Immunol; 1996 Jun; 104(3):446-53. PubMed ID: 9099929
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Elevated Layilin-Positive Monocyte Levels in the Peripheral Blood of Patients with Systemic Lupus Erythematosus Reflect Their Autoimmune Status.
    Liu C; Wang Y; Zhang YH; Yuan Z; Zhang Z; Zeng X; Guan Z; Bahabayi A; Lu S
    Immunol Invest; 2023 Nov; 52(7):879-896. PubMed ID: 37642473
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Deep Phenotyping of CD11c
    Rincon-Arevalo H; Wiedemann A; Stefanski AL; Lettau M; Szelinski F; Fuchs S; Frei AP; Steinberg M; Kam-Thong T; Hatje K; Keller B; Warnatz K; Radbruch A; Lino AC; Schrezenmeier E; Dörner T
    Front Immunol; 2021; 12():635615. PubMed ID: 33777025
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Abnormal lower expression of GPR183 in peripheral blood T and B cell subsets of systemic lupus erythematosus patients.
    Zhao M; Mei Y; Zhao Z; Cao P; Xin Y; Guo Y; Yang M; Wu H
    Autoimmunity; 2022 Nov; 55(7):429-442. PubMed ID: 35875859
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of immune subsets with distinct lectin binding signatures using multi-parameter flow cytometry: correlations with disease activity in systemic lupus erythematosus.
    Szabó E; Faragó A; Bodor G; Gémes N; Puskás LG; Kovács L; Szebeni GJ
    Front Immunol; 2024; 15():1380481. PubMed ID: 38774868
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Indicators of T-cell activation: correlation between quantitative CD38 expression and soluble CD8 levels in asymptomatic HIV+ individuals and healthy controls.
    Lenkei R; Bratt G; Holmberg V; Muirhead K; Sandström E
    Cytometry; 1998 Oct; 33(2):115-22. PubMed ID: 9773871
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characteristics and clustering analysis of peripheral blood lymphocyte subsets in children with systemic lupus erythematosus complicated with clinical infection.
    Deng Y; Ou YY; Mo CJ; Huang L; Qin X
    Clin Rheumatol; 2023 Dec; 42(12):3299-3309. PubMed ID: 37537315
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Upregulation of CD16- monocyte subsets in systemic lupus erythematous patients.
    Wu Z; Zhang S; Zhao L; Fei Y; Wang L; Li J; Wen X; Zeng X; Zhang F; Li Y
    Clin Rheumatol; 2017 Oct; 36(10):2281-2287. PubMed ID: 28821990
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD4
    Kato R; Sumitomo S; Tsuchida Y; Tsuchiya H; Nakachi S; Sakurai K; Hanata N; Nagafuchi Y; Kubo K; Tateishi S; Kanda H; Okamura T; Yamamoto K; Fujio K
    Front Immunol; 2019; 10():1619. PubMed ID: 31354747
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Disturbed peripheral B lymphocyte homeostasis in systemic lupus erythematosus.
    Odendahl M; Jacobi A; Hansen A; Feist E; Hiepe F; Burmester GR; Lipsky PE; Radbruch A; Dörner T
    J Immunol; 2000 Nov; 165(10):5970-9. PubMed ID: 11067960
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Do elevated levels of serum-soluble fas contribute to the persistence of activated lymphocytes in systemic lupus erythematosus?
    Bijl M; van Lopik T; Limburg PC; Spronk PE; Jaegers SM; Aarden LA; Smeenk RJ; Kallenberg GG
    J Autoimmun; 1998 Oct; 11(5):457-63. PubMed ID: 9802929
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Natural Killer and Natural Killer T Cells in Juvenile Systemic Lupus Erythematosus: Relation to Disease Activity and Progression.
    Zahran AM; Abdel-Rahim MH; Elsayh KI; Hassanien MM; Mahran SA; Hetta HF
    Arch Immunol Ther Exp (Warsz); 2019 Jun; 67(3):161-169. PubMed ID: 30944972
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dysregulated expression of CXCR4/CXCL12 in subsets of patients with systemic lupus erythematosus.
    Wang A; Guilpain P; Chong BF; Chouzenoux S; Guillevin L; Du Y; Zhou XJ; Lin F; Fairhurst AM; Boudreaux C; Roux C; Wakeland EK; Davis LS; Batteux F; Mohan C
    Arthritis Rheum; 2010 Nov; 62(11):3436-46. PubMed ID: 20722038
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.